Statistics for Summit Therapeutics (id:6474 SMMT)
Valuation metrics
Market cap
14.00B
Enterprise value
13.05B
Trailing P/E (ttm)
25.02
Forward P/E
-49.95
PEG ratio
-49.95
Price/Sales (ttm)
Price/Book (mrq)
31.95
Enterprise Value/Revenue
Enterprise Value/EBITDA
-71.90
Overview
Shares outstanding
737.45M
Float
105.06M
Shares short
17.04M
% Held by insiders
0.84%
% Held by institutions
0.12%
Average volume (10 days)
1.89M
Average volume (90 days)
Price summary
52-Week low
1.89
52-Week high
33.89
52-Week change
89.47%
Beta
-0.92
50-Day moving average
21.47
200-Day moving average
10.45
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-31.47%
Return on equity
-73.21%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-181,490,000.00
Net income to common (ttm)
-196,679,008.00
Diluted EPS (ttm)
-0.23
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
486.90M
Total cash per share (mrq)
0.66
Total debt (mrq)
32.50M
Total Debt/Equity (mrq)
7.42
Current ratio (mrq)
830.90%
Book value per share (mrq)
0.59
Cash flow
Cash flow statement
-112,892,000.00
Levered free cash flow (LFCF)
-62,823,624.00